Article Versions Notes

Hoertel N, Rezaei K, Sánchez-Rico M, Delgado-Álvarez A, Kornhuber J, Gulbins E, Olfson M, Ouazana-Vedrines C, Carpinteiro A, Cougoule C, et al. Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study. Pharmaceuticals. 2023; 16(8):1107. https://doi.org/10.3390/ph16081107

Hoertel, Nicolas, Katayoun Rezaei, Marina Sánchez-Rico, Alfonso Delgado-Álvarez, Johannes Kornhuber, Erich Gulbins, Mark Olfson, Charles Ouazana-Vedrines, Alexander Carpinteiro, Céline Cougoule, and et al. 2023. "Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study" Pharmaceuticals 16, no. 8: 1107. https://doi.org/10.3390/ph16081107

Hoertel, N., Rezaei, K., Sánchez-Rico, M., Delgado-Álvarez, A., Kornhuber, J., Gulbins, E., Olfson, M., Ouazana-Vedrines, C., Carpinteiro, A., Cougoule, C., Becker, K. A., Alvarado, J. M., Limosin, F., & on behalf of the AP-HP/Université Paris Cité/INSERM COVID-19 Research Collaboration, AP-HP COVID CDR Initiative and “Entrepôt de Données de Santé” AP-HP Consortium. (2023). Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study. Pharmaceuticals, 16(8), 1107. https://doi.org/10.3390/ph16081107